Neurocrine Biosciences Inc at Bank of America Healthcare Conference Transcript
Good afternoon. Welcome back to the Bank of America Healthcare Conference. It's my pleasure to have our next presenting company with us, Neurocrine. We've had the pleasure of covering Neurocrine now for several years. So sitting next to me are Kevin and Matt. I will let each of you introduce yourselves. And then maybe, Kevin, you can give us an overview of what's been happening with the company over the last year or so, and then we can go into a little bit more detailed Q&A, if that works.
That's great. Thank you, Tazeen. It's a pleasure being here in person with you and having the opportunity to be able to speak at this conference. So I'm Kevin Gorman. I'm the CEO of Neurocrine.
Matt Abernethy, CFO, joined the company about 4.5, 5 years ago.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |